ENCell Co., Ltd. (KOSDAQ:456070)
South Korea · Delayed Price · Currency is KRW 18,050
+1,100 (6.49%)
Jan 29, 2026, 3:30 PM KST
ENCell Market Cap
ENCell has a market cap or net worth of 197.09 billion as of January 29, 2026. Its market cap has increased by 6.48% in one year.
Market Cap
197.09B
Enterprise Value
180.05B
Revenue
5.91B
Ranking
n/a
PE Ratio
n/a
Stock Price
18,050.00
Market Cap Chart
Since August 23, 2024, ENCell's market cap has increased from 160.82B to 197.09B, an increase of 22.55%. That is a compound annual growth rate of 15.25%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 28, 2026 | 185.07B | -6.77% |
| Dec 30, 2025 | 198.50B | 7.25% |
| Dec 30, 2024 | 185.09B | 15.09% |
| Aug 23, 2024 | 160.82B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| JETEMA, | 333.79B |
| HLB Therapeutics | 293.85B |
| Helixmith | 277.66B |
| EASY BIO,Inc. | 233.23B |
| MedPacto | 226.56B |
| Genexine | 226.49B |
| Macrogen | 184.85B |
| GeneOne Life Science | 156.77B |